Navigation Links
Common human viruses threaten endangered great apes
Date:1/25/2008

Common human viruses are responsible for outbreaks of respiratory disease that have led to the decline of endangered chimpanzees in the wild, according to a study reported online on January 24th in Current Biology, a publication of Cell Press. The findingswhich are the first to provide direct evidence of virus transmission from humans to wild great apesillustrate the challenge of maximizing the benefit of research and tourism to great apes while minimizing the negative side effects that come with human contact, the researchers say.

Research and tourism has a strong positive effect on great apes survival since it reduces poaching activities in these areas and gives more political weight to the apes and protected areas, said Fabian Leendertz of Robert Koch-Institut and Max Planck Institute for Evolutionary Anthropology in Germany. [The spread of viruses] has been a concern, but people had never proven it. Our demographic analyses of chimpanzees suggest that this started as soon as people got close enough to chimps to transmit diseases. There is a correlation between habituationthe proximity between humans and chimpsand disease outbreaks.

Commercial hunting and habitat loss are major drivers of the rapid decline of great apes, the researchers said. Ecotourism and research have been widely promoted as a means of providing alternative value for apes and their habitats. While close contact between humans and habituated apes has raised concerns about disease transmission, previous studies had only demonstrated the spread of relatively mild bacterial and parasitic infections from humans to wild apes.

In the new study, the researchers gathered evidence from chimpanzees hit by five distinct respiratory outbreaks between 1999 and 2006 in Cte d'Ivoire, West Africa. The outbreaks sickened almost all of the chimps and led to a significant number of deaths.

All available tissue samples taken from chimps who had died tested positive for one of two paramyxoviruses: human respiratory syncytial virus (HRSV) or human metapneumovirus (HMPV), the researchers report. HRSV and HMPV are common causes of respiratory disease in humans and are the leading causes of lower respiratory disease in children and, in developing countries, a major source of infant mortality, the researchers said. In adults, HRSV and HMPV usually cause mild upper-respiratory-tract infection but can lead to more serious illnesses such as pneumonia.

The viruses we found are very common, Leendertz said. Antibody prevalence in humans is almost up to 100 percent, meaning almost everybody has had contact with these viruses.

Twenty-four years of mortality data from observed chimpanzees revealed that such respiratory outbreaks could have a long history, Leendertzs team reported. But, they added, there was some good news: Survey data show that research presence has had a strong positive effect in suppressing poaching around the research site.

The researchers have already stepped up guidelines to help minimize the disease risk to chimpanzees, and they urge others to do the same. For example, Leendertz said, they now maintain a distance of at least seven meters, wear masks, and disinfect their boots regularly.


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related medicine news :

1. Wyeth Declares Common and Preferred Stock Dividends
2. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
3. Rigel Announces Offering of 4,000,000 Shares of Common Stock
4. Infection With Common Parasite Raises Schizophrenia Risk
5. Surgical site infections more common than expected following breast procedures
6. Schering-Plough CEO to Buy $2 Million in Common Shares
7. Common molecule notifies immune system of prostate cancer
8. GHI and HIP Launch Pilot Medical Home Network Project with Support from Commonwealth Fund
9. Multiple skin cancer risk behaviors are common among US adults
10. Catheter chaos: Hospitals lag in preventing common infection
11. Colon cancer risk in US traced to common ancester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: